维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Zolnierek"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Sequential therapy with sorafenib and sunitinib in renal cell carcinoma 显示文摘	Dudek AZ Zolnierek J Dham A	2009	Cancer2009，115，1：	1
2	The R&D incentives ofindustry leaders 显示文摘	SEGERSTR0MP ZOLNIEREK J	1999	International Economic Review1999，，40：	1
3	New therspeutic options in systemic treatment of advanced cutaneous melanoma显示文摘	Mackiewicz-Wysocka M Zolnierek J Wysocki PJ	2013	Expert Opin Investig Drugs2013，22，2：	1
4	Sequential therapy with sorafenib and sunitinib in renal cell carcinoma显示文摘	Dudek AZ Zolnierek J Dham A	2009	Cancer2009，115，1：	1
5	The R&D Incentives of Industry Leaders显示文摘	Segerstrom Paul S Zolnierek James M		0，，03：	1
6	Physician communication and patient adherence to treatment: a meta -analysis 显示文摘	Zolnierek KB Dimatteo MR	2009	Med Care2009，47，8：	1
7	Sequential therapy with sorafenib and sunitinib in renal cell carcinoma显示文摘	Dudek AZ Zolnierek J Dham A	2009	Canc- er2009，115，1：	1
8	Sequential therapy with sor- afenib and sunitinib in renal cell carcinoma显示文摘	Dudek A Z Zolnierek J Dham A	2009	Cancer2009，115，5：	1
9	Mental health policy and integrated care: global per- spectives 显示文摘	Zolnierek CD	2008	J Psychiatr Ment Health Nurs2008，15，7：	1
10	The R&D incen rives of industry leaders显示文摘	SEGERSTROM P S ZOLNIEREK J M	1999	International Economic Review1999，40，74：	1
11	Antisense therapy in cancer显示文摘	Pawlak W Zolnierek J Sarosiek T	2000	Cancer Treat Rev2000，26，5：	1
12	The R&D incentives of industry leaders 显示文摘	SEGERSTROM P S ZOLNIEREK J M	1999	International Economic Review1999，40，3：	1
13	Recent developments in renal cell cancer immunotherapy 显示文摘	Wysocki PJ Zolnierek J Szczylik C	2007	Expert Opin Biol Ther2007，7，5：	1
14	Sequential therapy with sorafenib and sunitinib in renal cell carcinoma显示文摘	Dudek AZ Zolnierek J Dham A	2009	Journal of Cancer2009，115，1：	1
15	New therapeutic options in systemic treatment of advanced cutaneous melanoma显示文摘	Mackiewicz-Wysocka M Zolnierek J Wysocki PJ	2013	Expert Opin Investig Drugs2013，22，2：	1
16	Studies on the anticonvulsant activity of 4-alkyl-l,2,4-triazole-3-thiones and their effect on GABAergic system显示文摘	PLECH T KAPROiql B LUSZCZKI J J WUJEC M PANETH A SIWEK A KOLACZKOWSKI M ZOLNIEREK M NOWAK G	2014	European Journal Medicinal Chemistry2014，86，：	1
17	The R&D Incentives of Industry Leaders显示文摘	Segerstrom P Zolnierek J	1999	International Economic Review1999，40，75：	1
18	Sequential therapy with sor- afenib and sunitinib in renal cellcarcinoma 显示文摘	Dudek AZ Zolnierek J Dham A	2009	Cancer2009，115，1：	1
19	Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial显示文摘	Robert J Motzer Camillo Porta Nicholas J Vogelzang Cora N Sternberg Cezary Szczylik Jakub Zolnierek Christian Kollmannsberger Sun Young Rha Georg A Bjarnason Bohuslav Melichar Ugo De Giorgi Viktor Grünwald Ian D Davis Jae-Lyun Lee Emilio Esteban Gladys Ur	2014	Lancet Oncology2014，，：	1
20	Targeted therapy of renal cell cancer 显示文摘	Wysocki P J Zolnierek J Szczylik C et aI	2008	Curr Opin Investig Drugs2008，9，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示